Live Breaking News & Updates on Medicines Evaluation Unit

Stay updated with breaking news from Medicines evaluation unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Moleculin Receives Authorization from the Medicines and Healthcare Products Regulatory Agency (MHRA) to Commence Phase 1a Clinical Trial of WP1122 for the Treatment of COVID-19

/PRNewswire/ Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug. ....

United Kingdom , United States , City Of , Jenene Thomas , Walter Klemp , Moleculin Biotech Inc , Riverside Research Ethics Committee , Exchange Commission , Securities Exchange , Healthcare Products Regulatory Agency , Moleculin Biotech , Research Ethics Committee , Medicines Evaluation Unit , Investigational New Drug , Transcription Modulator , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act ,